Patent · US Active

8-alkynylxanthines and derivatives

US8044061B2 · kind B2 · utility

3Cited by

3References

10Claims

0Family size

Assignee

UCB Pharma GMBH · DE

Inventors

Christa E. Müller · Bonn, DE
Jorg Hockemeyer · Bonn, DE
Nikolay Tzvetkov · Bonn, DE
Joachim C. Burbiel · Bornheim, DE

Key dates

Filing date	Dec 21, 2007
Grant date	Oct 25, 2011
Priority date	—
Expiry date	Jan 15, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D473/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are novel compounds of the general formula (Ia), and pharmaceutically acceptable salts, isomers, diastereomers or enantiomers thereofand their use as medicines, for example in the treatment of dopamine-related movement disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.